Riskpilot← Back to searchSign inGet full accessAncor Holding AB
ABActiveOrg 5566825062Färögatan 33Research and experimental development on natural sciences and engineering · NACE 7210Est. 20052 employees
Revenue 2024
SEK 740K
-24% vs 2023
EBITDA margin
-2929.6%
+10% vs 2023
Equity ratio
36.1%
Financial strength
Net profit 2024
SEK -23,9M
+10% vs 2023
| Revenue | SEK 740K | -24% |
| EBITDA | SEK -21,7M | +10% |
| Net profit | SEK -23,9M | +10% |
| Total assets | SEK 21M | +4% |
| Equity | SEK 7,6M | -5% |
| Employees | 2 | — |
Legal name
Ancor Holding AB
Org number
5566825062
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
29 juni 2005
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Aktiebolagets verksamhet ska vara att utveckla och marknadsföra medicintekniska produkter, att bedriva medicinsk forskning och behandling samt därmed förenlig verksamhet.
Address
Färögatan 33
Phone
+46840011586
Email
corpadmin@chordate.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 618 | 882 | 109 | 976 | 740 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −15 664 | −17 812 | −22 352 | −24 081 | −21 679 |
| Depreciation & amort. | −2 568 | −1 541 | −2 453 | −2 453 | −2 219 |
| EBIT | −18 232 | −19 353 | −24 805 | −26 534 | −23 898 |
| Net financials | −6 | 11 | 80 | −7 | 6 |
| Profit before tax | −18 239 | −19 342 | −24 725 | −26 540 | −23 892 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −18 239 | −19 342 | −24 725 | −26 540 | −23 892 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 22 452 | 23 598 | 21 636 | 20 256 | 21 045 |
| Equity | 13 604 | 14 262 | 10 537 | 7 997 | 7 605 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8 847 | 9 337 | 11 099 | 12 259 | 13 440 |
| Total debt | 8 847 | 9 337 | 11 099 | 12 259 | 13 440 |
EBITDA margin
-2929.6%
This company
15.8%
Market median
-18642% vs market
20202024
Equity ratio
36.1%
This company
38.2%
Market median
+5% vs market
20202024
Return on equity
-314.2%
This company
18.4%
Market median
-1808% vs market
20202024
Net profit margin
-3228.6%
This company
8.1%
Market median
-39959% vs market
20202024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
1.77×
This company
0.62×
Market median
-185% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
BK Chief Executive Officer | Chief Executive Officer | 2026 |
HN Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2026 | |
| Chairman | 2026 | |
| Chairman | 2025 | |
| Board of Directors | 2026 | |
| Board of Directors | 2026 | |
| Former (3) | ||
| Board of Directors | 2022 – 2026 | |
| Board of Directors | 2022 – 2026 | |
| Chairman | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Chordate Medical Holding AB (publ)
Ancor Holding AB Board members of Ancor Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Karl Daniel Jilkén | Chief Executive Officer | 0 companies |
| Henrik Nils Gunnar Boman | Chief Auditor | 0 companies |
| Jan Tommy Lennart Hedberg | Board of Directors | 0 companies |
| Caroline V V Lundgren Brandberg | Board of Directors | 0 companies |
| Emmanuel Johannes Bengtsson | Board of Directors | 0 companies |
| Carina Mariana Terenius Jilkén | Chairman | 0 companies |
| Gunilla Ingeborg O Lundmark | Board of Directors | 0 companies |
| Sten Gunnar Otto Skolling | Chairman | 0 companies |
| Anders Henrik Weilandt | Board of Directors | 0 companies |
| Per Marcus Jönsson | Board of Directors | 0 companies |
| Nils Henrik Milton Rammer | Chairman | 0 companies |